Status:

COMPLETED

Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci

Lead Sponsor:

St. Jude Children's Research Hospital

Collaborating Sponsors:

Avadim Technologies, Inc.

Conditions:

Hematopoietic Stem Cell Transplantation

Vancomycin-Resistant Enterococci

Eligibility:

All Genders

Up to 21 years

Phase:

NA

Brief Summary

Healthcare-associated infections (HAI) are associated with substantial morbidity, mortality and health-care costs in children undergoing hematopoietic stem cell transplantation (HSCT). These infection...

Detailed Description

Participants will be randomized to receive either a daily bath with the experimental bath wipes, or the standard bath wipes, beginning on the day of admission, and to be used once daily for a period o...

Eligibility Criteria

Inclusion

  • Less than or equal to 21 years of age.
  • Scheduled to undergo either autologous or allogeneic hematopoietic stem cell transplant

Exclusion

  • Participant/Parent/Legally authorized representative (LAR) unwilling to give written informed consent.
  • (Female only) Known pregnancy (negative serum or urine pregnancy test to be conducted within 14 days prior to enrollment).
  • (Female only) Breast feeding

Key Trial Info

Start Date :

October 30 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 19 2017

Estimated Enrollment :

159 Patients enrolled

Trial Details

Trial ID

NCT02241005

Start Date

October 30 2014

End Date

September 19 2017

Last Update

October 6 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Jude Children's Research Hospital

Memphis, Tennessee, United States, 38105

Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci | DecenTrialz